GLP-1 medications and Evaluation & Management (E&M) services present two very different prior authorization challenges—one is high-volume and fast-moving, the other is nuanced and frequently blocked by PBM red tape. In this episode, Infinx's Jonathan Aguiar and Jennifer Glockzin break down how their team uses AI, automation, and hands-on intervention to streamline both, improving speed and accuracy while reducing provider burden.